These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35762293)

  • 1. Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Ruijs TQ; Koopmans IW; de Kam ML; van Esdonk MJ; Koltzenburg M; Groeneveld GJ; Heuberger JAAC
    Clin Pharmacol Ther; 2022 Nov; 112(5):1008-1019. PubMed ID: 35762293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over study.
    Ruijs TQ; Koopmans IW; de Kam ML; Tannemaat MR; Groeneveld GJ; Heuberger JAAC
    Clin Transl Sci; 2022 Dec; 15(12):2971-2981. PubMed ID: 36281627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
    Nochi Z; Pia H; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Fardo F; Genser B; Goetz M; Kostenko AV; Leone C; Li T; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Stouffs A; Tracey I; Troconiz IF; Truini A; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Tankisi H; Finnerup NB; Phillips KG; Treede RD
    Trials; 2022 Feb; 23(1):163. PubMed ID: 35183242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of mexiletine on excitability properties of human median motor axons.
    Kuwabara S; Misawa S; Tamura N; Kanai K; Hiraga A; Ogawara K; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Feb; 116(2):284-9. PubMed ID: 15661106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial.
    Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N;
    Muscle Nerve; 2021 Mar; 63(3):371-383. PubMed ID: 33340120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
    Lang N; Rothkegel H; Peckolt H; Deuschl G
    Seizure; 2013 Nov; 22(9):726-30. PubMed ID: 23778157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study.
    Ando K; Wallace MS; Braun J; Schulteis G
    Reg Anesth Pain Med; 2000; 25(5):468-74. PubMed ID: 11009231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
    Shibuya K; Misawa S; Kimura H; Noto Y; Sato Y; Sekiguchi Y; Iwai Y; Mitsuma S; Beppu M; Watanabe K; Fujimaki Y; Tsuji Y; Shimizu T; Mizuno T; Nakagawa M; Sawaguchi K; Hanaoka H; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):353-8. PubMed ID: 25960085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.
    Ruijs TQ; Heuberger JAAC; de Goede AA; Ziagkos D; Otto ME; Doll RJ; van Putten MJAM; Groeneveld GJ
    Br J Clin Pharmacol; 2022 Jun; 88(6):2926-2937. PubMed ID: 35028950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Heatwole C; Luebbe E; Rosero S; Eichinger K; Martens W; Hilbert J; Dekdebrun J; Dilek N; Zizzi C; Johnson N; Puwanant A; Tawil R; Schifitto G; Beck CA; Richeson JF; Zareba W; Thornton C; McDermott MP; Moxley R
    Neurology; 2021 Jan; 96(2):e228-e240. PubMed ID: 33046619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study.
    Wallace MS; Magnuson S; Ridgeway B
    Reg Anesth Pain Med; 2000; 25(5):459-67. PubMed ID: 11009230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).
    Yamada S; Hashizume A; Hijikata Y; Inagaki T; Ito D; Kinoshita F; Nakatochi M; Kobayashi Y; Hirakawa A; Nakamura T; Katsuno M
    BMJ Open; 2018 Sep; 8(9):e023041. PubMed ID: 30206090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
    Leone C; Di Stefano G; Di Pietro G; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Finnerup NB; Garcia-Larrea L; Li T; Goetz M; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Tracey I; Troconiz IF; Van Niel H; Hernandez JMV; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Truini A; Treede RD
    Trials; 2022 Sep; 23(1):739. PubMed ID: 36064434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial.
    Wu CL; Agarwal S; Tella PK; Klick B; Clark MR; Haythornthwaite JA; Max MB; Raja SN
    Anesthesiology; 2008 Aug; 109(2):289-96. PubMed ID: 18648238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
    Weiss MD; Macklin EA; Simmons Z; Knox AS; Greenblatt DJ; Atassi N; Graves M; Parziale N; Salameh JS; Quinn C; Brown RH; Distad JB; Trivedi J; Shefner JM; Barohn RJ; Pestronk A; Swenson A; Cudkowicz ME;
    Neurology; 2016 Apr; 86(16):1474-81. PubMed ID: 26911633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
    Stunnenberg BC; Raaphorst J; Groenewoud HM; Statland JM; Griggs RC; Woertman W; Stegeman DF; Timmermans J; Trivedi J; Matthews E; Saris CGJ; Schouwenberg BJ; Drost G; van Engelen BGM; van der Wilt GJ
    JAMA; 2018 Dec; 320(22):2344-2353. PubMed ID: 30535218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
    de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
    Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.
    Statland JM; Bundy BN; Wang Y; Rayan DR; Trivedi JR; Sansone VA; Salajegheh MK; Venance SL; Ciafaloni E; Matthews E; Meola G; Herbelin L; Griggs RC; Barohn RJ; Hanna MG;
    JAMA; 2012 Oct; 308(13):1357-65. PubMed ID: 23032552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
    Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
    Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
    de Greef BTA; Hoeijmakers JGJ; Geerts M; Oakes M; Church TJE; Waxman SG; Dib-Hajj SD; Faber CG; Merkies ISJ
    Brain; 2019 Feb; 142(2):263-275. PubMed ID: 30649227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.